Related Experiment Video
Updated: Jul 2, 2026
![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)
Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941
Published on: April 28, 2019
Block of Nav1.8 by small molecules.
Douglas S Krafte1, Mark Chapman, Brian Marron
1Icagen, Inc., Durham, North Carolina 14487, USA. DKRAFTE@icagen.com
New sodium channel blockers show varying potency across species. Researchers highlight the importance of interspecies testing for pain research and drug development, especially for Na(v)1.8 channels.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Voltage-dependent sodium channels, particularly subtypes like Na(v)1.8, are crucial for neuronal excitability and pain signaling.
- Previous research identified subtype-selective Na(v)1.8 blockers effective in preclinical pain models.
Purpose of the Study:
- To investigate interspecies differences in the potency of sodium channel blockers.
- To illustrate a specific Na(v)1.8 blocker exhibiting varied potency across species.
- To correlate the potency of blockers on recombinant versus native tetrodotoxin-resistant sodium channels.
Main Methods:
- Electrophysiological characterization of sodium channel blocker activity.
- Testing compounds on Na(v)1.8 channels from different species (recombinant and native).
- Analysis of potency variations and correlation between different channel preparations.
Main Results:
- Identified compounds with significant differences in Na(v)1.8 channel blocking potency between species.
- Demonstrated varying efficacy of a specific Na(v)1.8 blocker across different species.
- Observed correlations in potency between recombinant and native tetrodotoxin-resistant sodium channels.
Conclusions:
- Sodium channel blocker efficacy can vary significantly across species.
- Interspecies differences must be considered when developing new pain therapeutics or research tools.
- Further investigation into species-specific channel behavior is essential for accurate preclinical translation.
Related Concept Videos
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Pharmocokinetics
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Neuromuscular Junction And Blockade

